☆ 4.5 Article

FIB-4 and APRI for cirrhosis detection in a privately insured national cohort

JHEP REPORTS (2024)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

Isabel Graupera et al.

Summary: This study found that FIB-4 and NFS have suboptimal accuracy for screening fibrosis in low-prevalence populations, with a high risk of overdiagnosis and a non-negligible percentage of false-negatives. Waist circumference emerges as a potential method for identifying individuals at risk for liver fibrosis in the general population.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases

Pere Gines et al.

Summary: Cirrhosis is a highly prevalent global disease caused mainly by non-alcoholic fatty liver disease and alcohol-related liver diseases. Noninvasive methods can accurately assess liver fibrosis, and screening high-risk populations for liver fibrosis may have the potential to prevent disease progression.

HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL

Christian Labenz et al.

Summary: This study demonstrates that the implementation of a structured screening program using easily obtainable measures of liver function may increase the early detection rate of cirrhosis in the general population.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Public, Environmental & Occupational Health

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

Isabel Graupera et al.

Summary: This study aims to investigate the utility of non-invasive tools in identifying individuals with asymptomatic, advanced chronic liver disease in the general population. With 30,000 subjects from eight European countries, the study will assess liver stiffness and bloodwork to evaluate the cost-effectiveness of such screening tools.

BMC PUBLIC HEALTH (2022)

Add to Collection

Review Gastroenterology & Hepatology

Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review

Jenny Lee et al.

Summary: This study synthesized the existing literature on the ability of FIB-4, NFS, and APRI models in prognosticating NAFLD-related events. The results showed that these models have demonstrated good ability to risk stratify patients for liver-related morbidity and mortality, with inconsistent performance in predicting change in fibrosis stage. Further head-to-head studies are needed to validate their performance and refine models for prognosticating NAFLD events.

LIVER INTERNATIONAL (2021)

Add to Collection

Article Endocrinology & Metabolism

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

Romina Lomonaco et al.

Summary: This study assessed the prevalence of NAFLD and liver fibrosis in patients with type 2 diabetes mellitus, revealing that at least 15% of patients with T2DM and NAFLD have moderate-to-advanced fibrosis. Screening for liver disease can be enhanced using imaging and plasma diagnostic panels, as AST/ALT alone are inadequate as initial screening markers.

DIABETES CARE (2021)

Add to Collection

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community

Jane Chalmers et al.

FRONTLINE GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

Ankur Srivastava et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care

John F. Dillon et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

Stuart McPherson et al.

GUT (2010)

Add to Collection

Article Gastroenterology & Hepatology

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Amy G. Shah et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)

Add to Collection

Article Gastroenterology & Hepatology

Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes

Sophie Jacqueminet et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

Add to Collection

Article Gastroenterology & Hepatology

AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis

Aurora Loaeza-del-Castillo et al.

ANNALS OF HEPATOLOGY (2008)

Add to Collection

Article Gastroenterology & Hepatology

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

Richard K. Sterling et al.

HEPATOLOGY (2006)

Add to Collection

Article Gastroenterology & Hepatology

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C

C Lackner et al.

HEPATOLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.